Drug Type Bispecific antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism ACVR2A inhibitors(activin A receptor type 2A inhibitors), ACVR2B inhibitors(Activin receptor type-2B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Preclinical | Switzerland | 22 May 2024 |






